Literature DB >> 23060309

Epidemiological burden of postmenopausal osteoporosis in France from 2010 to 2020: estimations from a disease model.

H Cawston1, M Maravic, P Fardellone, A Gauthier, J A Kanis, J Compston, F Borgström, C Cooper, E McCloskey.   

Abstract

UNLABELLED: This article estimates the present and future burden of postmenopausal osteoporosis in France in women aged 50 years and over.
METHODS: We adapted an existing model developed for Sweden to France. For each year of the study from 1970 to 2020, the 'incident cohort' (women experiencing a first osteoporotic fracture) was identified and run through a Markov model using annual cycles. Health states were based on the number of fractures (hip, vertebral, non-hip non-vertebral) and deaths. Transition probabilities reflected fracture site-specific risks of subsequent fractures and of death. Country-specific model inputs included population size and life tables from 1970 to 2020 and incidence of hip fracture.
RESULTS: The model estimated that the number of postmenopausal osteoporotic women was expected to increase from 3.0 million to 3.4 million between 2010 and 2020 (+15.3 %). Assuming that the incidence of fracture by age group does not change over time, the model predicted that the overall number of osteoporotic fractures would increase from 204,234 fractures in 2010 to 241,261 in 2020 (+18.1 %), hip (20.3 %), vertebral (19.0 %) and non-hip non-vertebral fractures (17.0 %).
CONCLUSION: The aging of the population is expected to drive a marked increase in the prevalence of osteoporosis and in the number of osteoporotic fractures. These data may assist future planning for appropriate heath care provision.

Entities:  

Mesh:

Year:  2012        PMID: 23060309     DOI: 10.1007/s11657-012-0102-3

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  9 in total

1.  Forecasting the burden of future postmenopausal hip fractures.

Authors:  T K Omsland; J H Magnus
Journal:  Osteoporos Int       Date:  2014-07-01       Impact factor: 4.507

2.  The ageing endocrine system: Fracture risk after initiation of antihypertensive therapy.

Authors:  Lars Rejnmark
Journal:  Nat Rev Endocrinol       Date:  2013-02-05       Impact factor: 43.330

3.  Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial.

Authors:  B Merle; R Chapurlat; E Vignot; T Thomas; J Haesebaert; A-M Schott
Journal:  Osteoporos Int       Date:  2017-02-28       Impact factor: 4.507

4.  Before and after hip fracture, vitamin D deficiency may not be treated sufficiently.

Authors:  S Maier; E Sidelnikov; B Dawson-Hughes; A Egli; R Theiler; A Platz; H B Staehelin; H-P Simmen; C Meier; W Dick; D Grob; A von Eckardstein; H A Bischoff-Ferrari
Journal:  Osteoporos Int       Date:  2013-05-29       Impact factor: 4.507

Review 5.  Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures.

Authors:  N C W Harvey; E V McCloskey; P J Mitchell; B Dawson-Hughes; D D Pierroz; J-Y Reginster; R Rizzoli; C Cooper; J A Kanis
Journal:  Osteoporos Int       Date:  2017-02-07       Impact factor: 4.507

6.  Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA.

Authors:  J Bousquet; M Bewick; A Cano; P Eklund; G Fico; N Goswami; N A Guldemond; D Henderson; M J Hinkema; G Liotta; A Mair; W Molloy; A Monaco; I Monsonis-Paya; A Nizinska; H Papadopoulos; A Pavlickova; S Pecorelli; A Prados-Torres; R E Roller-Wirnsberger; D Somekh; C Vera-Muñoz; F Visser; J Farrell; J Malva; K Andersen Ranberg; T Camuzat; A M Carriazo; G Crooks; Z Gutter; G Iaccarino; E Manuel de Keenoy; G Moda; L Rodriguez-Mañas; T Vontetsianos; C Abreu; J Alonso; C Alonso-Bouzon; J Ankri; M T Arredondo; F Avolio; A Bedbrook; A Z Białoszewski; H Blain; R Bourret; M F Cabrera-Umpierrez; A Catala; R O'Caoimh; M Cesari; N H Chavannes; J Correia-da-Sousa; T Dedeu; M Ferrando; M Ferri; W J Fokkens; F Garcia-Lizana; O Guérin; P W Hellings; T Haahtela; M Illario; M C Inzerilli; K C Lodrup Carlsen; P Kardas; T Keil; M Maggio; A Mendez-Zorrilla; E Menditto; J Mercier; J P Michel; R Murray; M Nogues; I O'Byrne-Maguire; D Pappa; A S Parent; M Pastorino; C Robalo-Cordeiro; B Samolinski; P Siciliano; A M Teixeira; S I Tsartara; A Valiulis; O Vandenplas; T Vasankari; B Vellas; M Vollenbroek-Hutten; M Wickman; A Yorgancioglu; T Zuberbier; M Barbagallo; G W Canonica; L Klimek; S Maggi; W Aberer; C Akdis; I M Adcock; I Agache; C Albera; F Alonso-Trujillo; M Angel Guarcia; I Annesi-Maesano; J Apostolo; S H Arshad; V Attalin; A Avignon; C Bachert; I Baroni; E Bel; M Benson; C Bescos; F Blasi; C Barbara; K C Bergmann; P L Bernard; S Bonini; P J Bousquet; B Branchini; C E Brightling; V Bruguière; C Bunu; A Bush; D P Caimmi; M A Calderon; G Canovas; V Cardona; K H Carlsen; A Cesario; E Chkhartishvili; R Chiron; T Chivato; K F Chung; M d'Angelantonio; G De Carlo; D Cholley; F Chorin; B Combe; B Compas; D J Costa; E Costa; O Coste; A-L Coupet; G Crepaldi; A Custovic; R Dahl; S E Dahlen; P Demoly; P Devillier; A Didier; A T Dinh-Xuan; R Djukanovic; D Dokic; G Du Toit; R Dubakiene; A Dupeyron; R Emuzyte; A Fiocchi; A Wagner; M Fletcher; J Fonseca; B Fougère; A Gamkrelidze; G Garces; J Garcia-Aymeric; B Garcia-Zapirain; B Gemicioğlu; C Gouder; B Hellquist-Dahl; I Hermosilla-Gimeno; D Héve; C Holland; M Humbert; M Hyland; S L Johnston; J Just; M Jutel; I P Kaidashev; M Khaitov; O Kalayci; A F Kalyoncu; W Keijser; H Kerstjens; J Knezović; M Kowalski; G H Koppelman; T Kotska; M Kovac; I Kull; P Kuna; V Kvedariene; V Lepore; W MacNee; M Maggio; A Magnan; I Majer; P Manning; M Marcucci; T Marti; M Masoli; E Melen; N Miculinic; F Mihaltan; B Milenkovic; J Millot-Keurinck; H Mlinarić; I Momas; S Montefort; M Morais-Almeida; T Moreno-Casbas; R Mösges; J Mullol; R Nadif; M Nalin; E Navarro-Pardo; K Nekam; G Ninot; D Paccard; S Pais; E Palummeri; P Panzner; N K Papadopoulos; C Papanikolaou; G Passalacqua; E Pastor; M Perrot; D Plavec; T A Popov; D S Postma; D Price; N Raffort; J C Reuzeau; J M Robine; F Rodenas; F Robusto; N Roche; A Romano; V Romano; J Rosado-Pinto; F Roubille; F Ruiz; D Ryan; T Salcedo; P Schmid-Grendelmeier; H Schulz; H J Schunemann; E Serrano; A Sheikh; M Shields; N Siafakas; N Scichilone; P Siciliano; I Skrindo; H A Smit; S Sourdet; E Sousa-Costa; O Spranger; T Sooronbaev; V Sruk; P J Sterk; A Todo-Bom; J Touchon; D Tramontano; M Triggiani; S I Tsartara; A L Valero; E Valovirta; E van Ganse; M van Hage; M van den Berge; O Vandenplas; M T Ventura; I Vergara; G Vezzani; D Vidal; G Viegi; M Wagemann; B Whalley; M Wickman; N Wilson; P K Yiallouros; M Žagar; A Zaidi; M Zidarn; E J Hoogerwerf; J Usero; R Zuffada; A Senn; B de Oliveira-Alves
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

7.  High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study.

Authors:  Tsung-Kun Lin; Yi-Sheng Liou; Ching-Heng Lin; Pesus Chou; Gwo-Ping Jong
Journal:  Clin Epidemiol       Date:  2018-01-18       Impact factor: 4.790

8.  Trends of Incidence, Mortality, and Future Projection of Spinal Fractures in Korea Using Nationwide Claims Data.

Authors:  Tae-Young Kim; Sunmee Jang; Chan-Mi Park; Ahreum Lee; Young-Kyun Lee; Ha-Young Kim; Eun-Hee Cho; Yong-Chan Ha
Journal:  J Korean Med Sci       Date:  2016-03-25       Impact factor: 2.153

9.  Association between gastrointestinal events and osteoporosis treatment initiation in women diagnosed with osteoporosis in France: a retrospective analysis.

Authors:  Bernard Cortet; Ankita Modi; Jackson Tang; Chun-Po Steve Fan; Shiva Sajjan; Jessica Papadopoulos Weaver
Journal:  BMC Musculoskelet Disord       Date:  2016-04-30       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.